Navigation Links
Central Nervous System Drug Delivery Specialists
Date:9/20/2012

NEW YORK, Sept. 20, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Central Nervous System Drug Delivery Specialists

http://www.reportlinker.com/p0968547/Central-Nervous-System-Drug-Delivery-Specialists.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The blood-brain barrier (BBB) is so effective at limiting the passage of exogenous substances that many drugs with the potential to treat CNS diseases are rendered ineffective by their inability to reach their target. Consequently, companies that develop innovative delivery technologies are in a position to play a vital role in CNS drug development.Identify the leading companies with innovative technologies designed to enhance CNS drug delivery.Compare the technologies that each company has developed and the diseases to which they are being applied.Evaluate each company's pipeline of products and the intellectual property on which these are based.Assess the alliances that have been formed to maximize the opportunities for commercial exploitation of the innovations.

Many drug delivery specialists have developed novel technology platforms to improve the passive or active transport of therapeutics across the blood-brain barrier through the encapsulation of drugs within liposomes (ArmaGen Technologies, Corden Pharma Switzerland), bolaamphiphilic vesicles (Lauren Sciences), and nanoparticles (to-BBB Technologies).

There has been success in circumventing the BBB by developing biodegradable implants (Durect Corporation) and programmable infusion devices (DePuy, Flowonix, Medtronic) for the localized delivery of drugs.

Intranasal delivery, which allows direct nose-to-brain access through the olfactory region, holds much promise. Medical device companies Kurve Technology, Impel NeuroPharma, and OptiNose have all developed devices that are compatible with intranasal delivery, and several products are now under evaluation.

Which companies are at the cutting-edge of CNS drug delivery technology?How extensive are the patent portfolios supporting the company's innovations?What alliances have been formed to accelerate the commercial exploitation of the delivery technologies?What are the prospects of success for each company's technological innovations?

EXECUTIVE SUMMARY•Key findings

Drug delivery specialists, strategic alliances, and intellectual property•Leading companies - Alkermes

- Angiochem

- ArmaGen Technologies

- biOasis Technologies

- Corden Pharma Switzerland LCC

- D-Pharm

- Durect Corporation

- Flowonix Medical

- Impel NeuroPharma

- Kurve Technology

- Lauren Sciences

- Medtronic

- OptiNose

- Raptor Pharmaceutical Corporation

- to-BBB Technologies BV

•Conclusions

Appendix•Scope

•Methodology - Acknowledgements

•Abbreviations•Bibliography/referencesTABLES•Table: Innovative drug delivery specialists targeting unmet clinical need in the CNSCompanies MentionedAlkermes plc, Arriva plc, Avista Corporation, Business Development Bank of Canada, DURECT Corporation, First Aviation Services Inc., GE Healthcare, Genmab A/S, Genzyme Corporation, Geron Corporation, GlaxoSmithKline Plc, Groupe Lactalis, Hutchison 3G UK Limited, Janssen Pharmaceuticals, Inc., Nestlé SA, Publicis Groupe SA, Synthes Inc., The LEGO Group

To order this report: Drug_Delivery_Technology Industry: Central Nervous System Drug Delivery Specialists

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Advances in Delivery to the Central Nervous System
2. South and Central America Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
3. Central Logic Poised for Rapid Expansion with New Financial Partner Mercato Partners
4. Cancer Patients in Central Vietnam to Gain Access to Advanced Radiotherapy Treatments Using Technology from Varian Medical Systems
5. Central Logic Named To 2012 Inc. 500 Fastest Growing Private Companies
6. German-based Contract Research Organization Verum.de Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech
7. FDA Approves NDA Supported By MedAvante Central Ratings
8. The Outlook for Medical Devices in Central Asia
9. Global Central Nervous System Drugs Market 2011-2015
10. South Korean lawmakers one step from rigorous new system for stem cell Advancement: scientists, physicians and patients applaud, urge lawmakers to complete The Job
11. CentraMed and HT Systems Partner to Improve Financial Performance of Hospitals and Physicians Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... FRISCO, Texas , Dec. 8, 2016 /PRNewswire/ ... new program that brings leading-edge laboratory services and ... the United States , allowing more doctors ... and health care management solutions. Logo ... Hospital systems, under pressure to ...
(Date:12/8/2016)... , December 8, 2016 Information products ... metrics in Scopus , the world,s largest abstract ... access to comprehensive metrics for journals from over 5,000 publishers. The ... which journals to subscribe to and when to adjust a journal,s ... , , ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill the ... amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates ... be set up in a matter of minutes, or even seconds. The SAFETY STRAP ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... said an inventor from Winchester, Va. "I thought that if the nebulizer had a ... treatments rather than fearing them." , He developed the patent-pending NEBY to avoid the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking ... registration today for its 33rd Annual Issues & Research Conference, March 2-3, ... theme of the conference is “Persistent Challenges and New Opportunities: Using Research to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) ... , the ultimate weight loss and wellness program, at their world headquarters of Omni ... provide immediate and long-term results to anyone seeking weight loss, personal development, a healthy ...
Breaking Medicine News(10 mins):